Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU (EPIC-ICU)

NCT07399054 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.

NCT NCT07399054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07399054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU (EPIC-ICU)
Lead sponsor
Asian Institute of Gastroenterology, India
Phase
Observational
Overall status
Recruiting
Start date
February 23, 2026
Completion date
February 23, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reflux episodes, stress ulcers